2026 ICD-10-CM Diagnosis Code Z15.81Genetic susceptibility to multiple endocrine neoplasia [MEN]
Z15.81 is a billable ICD-10-CM diagnosis code for genetic susceptibility to multiple endocrine neoplasia [MEN]. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. Coders also document this condition as genetic predisposition to multiple endocrine adenomatosis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Genetic susceptibility to disease.
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for Z15.81.
Present on Admission (POA)Billing
Z15.81 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Genetic predisposition to multiple endocrine adenomatosis
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Type 1 Excludes
- multiple endocrine neoplasia MEN syndromes E31.2
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Genetic
- susceptibility to disease NEC - Z15.89
- multiple endocrine neoplasia - Z15.81
- Susceptibility to disease, genetic - Z15.89
- multiple endocrine neoplasia - Z15.81
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Genetic
- susceptibility to disease NEC
- multiple endocrine neoplasia
- Susceptibility to disease, genetic
- multiple endocrine neoplasia
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Multiple endocrine neoplasia
Multiple endocrine neoplasia is a group of disorders that affect the body's network of hormone-producing glands called the endocrine system. Hormones are chemical messengers that travel through the bloodstream and regulate the function of cells and tissues throughout the body.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Z15.81 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Z15.81Overview
Is Z15.81 (Genetic susceptibility to other disease) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report genetic susceptibility to multiple endocrine neoplasia [MEN] on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Can Z15.81 be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because genetic susceptibility to multiple endocrine neoplasia [MEN] describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.
Is Z15.81 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for genetic susceptibility to multiple endocrine neoplasia [MEN] on inpatient claims.
What is the ICD-9 equivalent of Z15.81?
Under the General Equivalence Mappings, genetic susceptibility to multiple endocrine neoplasia [MEN] converts to ICD-9-CM V84.81 (genetc sus mult endo neo). The mapping is a direct match.
